India to Japan: Lenalidomide Export Trade Route
India has recorded 2 verified shipments of Lenalidomide exported to Japan, representing a combined trade value of $5.5M USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $2.8M USD. The leading Indian exporter is HETERO LABS LIMITED, which accounts for 100% of total export value with 2 shipments worth $5.5M USD. On the buying side, XXC (XXNG XXNG)XXO XXD is the largest importer in Japan with $5.5M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Japan Lenalidomide corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $5.5M USD. The route is dominated by HETERO LABS LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's lenalidomide manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $2.8M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 23.6%, placing it at rank #4 among India's top lenalidomide export destinations globally.
On the import side, key buyers of Indian lenalidomide in Japan include XXC (XXNG XXNG)XXO XXD. XXC (XXNG XXNG)XXO XXD is the single largest importer with 2 shipments valued at $5.5M USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portAPIIC PHARMA SEZ
Market Position
- Global rank#4
- Annual growth+23.6%
- Demand growth+21.8%
- Regulatory ease68/100
Top 10 Indian Lenalidomide Exporters to Japan
Showing top 10 of 1 Indian suppliers exporting Lenalidomide to Japan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HETERO LABS LIMITED Avg $2.8M per shipment | 2 | $5.5M | 100.0% |
This table shows the top 10 of 1 Indian companies exporting lenalidomide to Japan, ranked by total trade value. The listed exporters are: HETERO LABS LIMITED. HETERO LABS LIMITED is the dominant supplier with 2 shipments worth $5.5M USD, giving it a 100% market share.
Top 10 Lenalidomide Importers in Japan
Showing top 10 of 1 known buyers in Japan receiving Lenalidomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lenalidomide in Japan include XXC (XXNG XXNG)XXO XXD. The largest importer is XXC (XXNG XXNG)XXO XXD, accounting for $5.5M USD across 2 shipments — representing 100% of all lenalidomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | XXC (XXNG XXNG)XXO XXD | 2 | $5.5M | 100.0% |
Top 10 Lenalidomide Formulations Imported by Japan
Showing top 10 of 2 product formulations shipped on the India to Japan Lenalidomide route, ranked by trade value
Japan imports a wide range of lenalidomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LENALIDOMIDE 5MG CAPSULES (20X10'S) — accounts for $5.5M USD across 1 shipments. A total of 2 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LENALIDOMIDE 5MG CAPSULES (20X10'S) | 1 | $5.5M | 99.1% |
| 2 | LENALIDOMIDE 2.5MG CAPSULES (20X10'S) | 1 | $48.9K | 0.9% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
APIIC PHARMA SEZ handles the highest volume with 2 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's lenalidomide exports to Japan are driven primarily by a handful of large-scale manufacturers. HETERO LABS LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Japan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — HETERO LABS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $2.8M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as lenalidomide 2.5mg capsules (20x10's), suggesting that buyers in Japan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, XXC (XXNG XXNG)XXO XXD is the largest importer with 2 shipments worth $5.5M USD — representing 100% of all lenalidomide imports from India on this route.
Route Statistics
- Trade Volume
- $5.5M
- Avg. Shipment
- $2.8M
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~25 days
- Annual Growth
- +23.6%
Related Analysis
Reverse Direction
Japan → India — Lenalidomide (Import)Other Lenalidomide Routes
Unlock the Full India to Japan Lenalidomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 2 shipments on this route.
Frequently Asked Questions — India to Japan Lenalidomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lenalidomide to Japan?
The leading Indian exporters of Lenalidomide to Japan are HETERO LABS LIMITED. HETERO LABS LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Lenalidomide exports from India to Japan?
India exports Lenalidomide to Japan worth approximately $5.5M USD across 2 recorded shipments. The average value per shipment is $2.8M USD.
Q Which ports does India use to ship Lenalidomide to Japan?
The most active port of origin is APIIC PHARMA SEZ with 2 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Japan for Lenalidomide?
The average transit time for Lenalidomide shipments from India to Japan is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Japan Lenalidomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 23.6% with demand growth tracking at 21.8%. The route is ranked #4 among India's top Lenalidomide export destinations globally.
Q How many suppliers are active on the India to Japan Lenalidomide route?
There are currently 1 active Indian suppliers exporting Lenalidomide to Japan. The market is moderately concentrated with HETERO LABS LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Lenalidomide from India in Japan?
The leading importers of Indian Lenalidomide in Japan include XXC (XXNG XXNG)XXO XXD. XXC (XXNG XXNG)XXO XXD is the largest buyer with 2 shipments worth $5.5M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Japan export trade corridor identified from Indian Customs (DGFT) records for Lenalidomide.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Japan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 2 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists